Open Access Open Access  Restricted Access Subscription Access

A Strategy for the Development of a Combination SARS-CoV-2 Vaccine Containing a DNA Vaccine (ZyCoV-D) and an Inactivated Virus Vaccine (Covaxin)


Affiliations
1 Department of Biochemistry, Indian Institute of Science, Bengaluru 560 012, India
 

No Abstract.

Keywords

No Keywords.
User
Notifications
Font Size

  • Biswas, S., Ashok, M. S., Reddy, G. S., Srinivasan, V. A. and Rangarajan, P. N., Curr. Sci., 1999, 76, 1012–1016.
  • Biswas, S., Kalanidhi, A. P., Ashok, M. S., Reddy, G. S., Srinivasan, V. A. and Rangarajan, P. N., Indian J. Exp. Biol., 2001, 39, 533–536.
  • Biswas, S., Reddy, G. S., Srinivasan, V. A. and Rangarajan, P. N., Human Gene Ther., 2001, 12, 1917–1922.
  • Kumar, P. U. et al., Vaccine, 2006, 24, 2790–2798.
  • Dinesh Kumar, B. et al., Indian J. Med. Res., 2013, 137, 1072–1088.
  • Bharati, K. and Vrati, S., Indian J. Med. Res., 2013, 137, 1027–1028.
  • Rangarajan, P. N., Srinivasan, V. A., Reddy, G. S. and Biswas, S., PCT patent # WO/ 2002/078732, Indian patent # 207234, 2007.

Abstract Views: 322

PDF Views: 138




  • A Strategy for the Development of a Combination SARS-CoV-2 Vaccine Containing a DNA Vaccine (ZyCoV-D) and an Inactivated Virus Vaccine (Covaxin)

Abstract Views: 322  |  PDF Views: 138

Authors

Pundi N. Rangarajan
Department of Biochemistry, Indian Institute of Science, Bengaluru 560 012, India

Abstract


No Abstract.

Keywords


No Keywords.

References





DOI: https://doi.org/10.18520/cs%2Fv121%2Fi11%2F1402-1402